Article
Deletion of chromosomes 13q and 14q is a common feature of tumors with BRCA2 mutations.
PloS one - 1 Jan 2012
Rouault Audrey, Banneau Guillaume, Macgrogan Gaëtan, Jones Natalie, Elarouci Nabila, Barouk-Simonet Emmanuelle, Venat Laurence, Coupier Isabelle, Letouzé Eric, de Reyniès Aurélien, Bonnet Françoise, Iggo Richard, Sévenet Nicolas, Longy Michel
Abstract excerpt
INTRODUCTION: Germline BRCA1 or BRCA2 mutations account for 20-30% of familial clustering of breast cancer. The main indication for BRCA2 screening is currently the family history but the yield of mutations identified in patients selected this way is low. METHODS: To develop more efficient approaches to screening we have compared the gene expression and genomic profiles of BRCA2-mutant breast tumors with those of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
